New diabetes pill orforglipron achieves uniform weight loss for women of all ages

The Medical News ·
Health & Medicine United Kingdom

New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) show that the new daily oral weight loss / type 2 diabetes medication orforglipron was associated with similar weight loss for women of different ages and at different life stages – premenopausal, experiencing menopause, or post-menopausal.

Read original article on The Medical News →

Related news